Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-518-2 | CAS number: 142-03-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Based on a skin sensitisation study according to OECD 406 the test item is not classified as sensitiser [reference 7.4.1 -1].
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 10 August 2017 - 13 November 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test substance is a metal salt for which the local lymph node assay (LLNA) is not recommended. It is known that the LLNA produces false negative results for metal salts (NTP, 1999, NIH Publication No. 99-4494). Therefore the guinea pig maximisation test (GPMT) was performed instead of the LLNA.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: ENVIGO RMS B.V., Kreuzelweg 53, 5961 NM Horst, Netherlands
- Weight at study initiation: 258 – 428 g
- Housing: 5 animals/cage
- Diet: S & K LAP rabbit diet, ad libitum.
- Water: tap water from municipal supply as for human consumption, containing 50 mg/100 mL ascorbic acid, ad libitum.
- Acclimation period: 14 days
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 ± 3
- Humidity (%): 30 - 70
- Air changes (per hr): > 10
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- intra-dermal: 5 % / 0.1 mL/site; dermal: 40 % / 0.5 mL
- Day(s)/duration:
- intra-dermal: day 1 / 24 hours; dermal: day 8 / 48 hours
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- 40 % (w/v)
- Day(s)/duration:
- two weeks after the dermal treatment / 24 hours
- No. of animals per dose:
- test group: 20, control group: 10
- Details on study design:
- RANGE FINDING TESTS: A preliminary dose range finding study was performed to select the doses of the main study.
MAIN STUDY
A. INDUCTION EXPOSURE (Intra-dermal Induction Exposure):
- Test group:
2 injections with 0.10 mL of Freund's Adjuvant mixed with physiological saline (1:1 v/v),
2 injections with 0.10 mL of the test item (5 %) homogenized physiological saline,
2 injections with 0.10 mL of test item (5 %), formulated in a 1:1 (v/v) mixture of Freund's Adjuvant and physiological saline
- Control group:
2 injections with 0.1 mL mix of Freund's Adjuvant and physiological saline (1:1)(v/v),
2 injections with 0.1 mL of physiological saline,
2 injections with 0.1 mL of 50 % v/v formulation of the physiological saline in a 1:1 mixture (v/v) Freund's Adjuvant and physiological saline.
- Exposure period: 24 hours
B. INDUCTION EXPOSURE (Dermal Induction Exposure):
Six days after the intra-dermal injections, in all animals the test area was painted with 0.5 mL of 10 % sodium dodecyl sulphate in Vaseline 24 h prior to topical induction application, in order to create a local irritation.
- Test group:
Approximately 24 hours after the painting, the test animals were exposed to test item. Closed patches were applied in the following manner: in case of the test animals a 5x5 cm patch of sterile gauze was saturated with 0.5 mL test item at concentration of 40 % and placed over the injection sites of the animals. These gauze patches were kept in contact with the skin by a patch with a surrounding adhesive hypoallergenic plaster. The exposed areas were covered for 48 hours with 4 layers of porous gauze pads and fully occlusive foil fastened with "Leucoplast" (Closed Patch Test). After the dermal induction exposition the rest of the test item was removed with water of body temperature.
- Control group:
Approximately 24 hours after the painting, the control animals were treated with physiological saline, as vehicle. All control animals were treated dermally with 0.50 mL of vehicle and the dressing was prepared and applied as for the test animals.
C. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day of challenge: 14 days after the dermal treatment the animals were exposed to the challenge dose.
- Exposure period: 24 hours
- Test group and Control group: 24 hours before the challenge treatment the left and the right flank areas (5x5 cm) of each animal were prepared for application. The hair was clipping from an approximate area 6x8 cm on the left and right flank of each animals. The challenge was performed as a dermal exposure (Closed Patch Test). Left shaved flank areas of the animals (both the test and the control) were treated with 0.5 mL of the test item (at concentration of 40 %). The right shaved flank areas were treated with 0.5 mL of vehicle, in all cases.
- Site: left and right flank
- Concentrations: 40 %
- Evaluation: 24 and 48 hours after patch removal - Positive control substance(s):
- no
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- no clinical signs
- Remarks on result:
- no indication of skin sensitisation
- Group:
- positive control
- Remarks on result:
- not measured/tested
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- It can be assumed that the experimental result of the test item is also valid for the anhydrous test item. No signs of contact sensitisation were detected in guinea pigs exposed to the test item. In the control and treated animals the means of the scores of dermal reaction were 0.00 according to the 24 and 48-hour results of the challenge phase. Therefore, the test item is not classified as sensitiser.
- Executive summary:
A skin sensitisation study was performed according to Magnusson-Kligman method using Freund's complete adjuvant technique to evaluate the sensitisation potential of test item. 20 test animals were subjected to sensitisation procedures with two routes of administration for the induction phase, i.e. an intra-dermal treatment and a topical application. The test item was used at concentration of 5 % for intra-dermal injections and at concentration of 40 % for dermal sensitisation treatment. Two weeks following the last induction exposure, a challenge dose (at concentration of 40 %) was administered to check elicitation. Challenge was performed by dermal application of the test item for 24 hours (Closed Patch Test). 10 control guinea pigs were simultaneously exposed to vehicle during the induction phase and they were treated with the test item (at concentration of 40 %) only for the challenge phase, i.e. the elicitation phase.
No signs of contact sensitisation were detected in guinea pigs exposed to the test item. In the control and treated animals the means of the scores of dermal reaction were 0.00 according to the 24 and 48-hour results of the challenge phase. Therefore, the test item is not classified as sensitiser. It can be assumed that the experimental result of the test item is also valid for the anhydrous test item.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
A skin sensitisation study was performed according to Magnusson-Kligman method using Freund's complete adjuvant technique to evaluate the sensitisation potential of test item. 20 test animals were subjected to sensitisation procedures with two routes of administration for the induction phase, i.e. an intra-dermal treatment and a topical application. The test item was used at concentration of 5 % for intra-dermal injections and at concentration of 40 % for dermal sensitisation treatment. Two weeks following the last induction exposure, a challenge dose (at concentration of 40 %) was administered to check elicitation. Challenge was performed by dermal application of the test item for 24 hours (Closed Patch Test). 10 control guinea pigs were simultaneously exposed to vehicle during the induction phase and they were treated with the test item (at concentration of 40 %) only for the challenge phase, i.e. the elicitation phase.
No signs of contact sensitisation were detected in guinea pigs exposed to the test item. In the control and treated animals the means of the scores of dermal reaction were 0.00 according to the 24 and 48-hour results of the challenge phase. Therefore, the test item is not classified as sensitiser. It can be assumed that the experimental result of the test item is also valid for the anhydrous test item.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Classification, Labeling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. Based on this data, the substance is not considered to be classified for skin sensitisation under Regulation (EC) No 1272/2008, as amended for the twelfth time in Regulation (EC) No 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.